Wayne, NJ, JULY 27, 2016 – Konica Minolta announced today the release of its most advanced X-ray Digital Radiography (DR) system.  Combining the unique built-from-the-ground-up design along with the fast and advanced Ultra image processing software, the system offers unprecedented workflow, clinical, patient convenience and satisfaction benefits. The new DR system (name not yet revealed) will be unveiled at the annual Association of Medical Imaging Management (AHRA 2016) conference in Nashville, July 31-August 3.

The Association for Medical Imaging Management’s Annual Meeting featured a keynote speech from Scott Steinberg titled, “Leading with Innovation: How to Future-Proof Yourself, Fearlessly Innovate, and Succeed in the New Normal.” Sponsored by Fujifilm, the speecg was a part of the ongoing commitment to education at AHRA 2016 

Reducing radiation dose is one of the biggest topics in modern medical imaging, and it’s something Dominic Siewko, Philips’ radiation health and safety officer, has specialized in for a number of years now.

Researchers from the University of Houston have developed a high-temperature superconducting coil for magnetic resonance imaging (MRI) scanners that can lead to images with higher resolution when compared to conventional coils.

WBR technology increases patient safety and comfort, reduces nuclear radiation doses, and shortens scan times.

3Scan, a San Francisco-based pathology technology company focused on the imaging of tissue samples, announced this week it has raised $14 million in Series B financing. The funding was led by existing investors Lux Capital and Data Collective, with additional funding from Dolby Family Ventures, OS Fund, Comet Labs and Breakout Ventures. 

Researchers believe diffusion-weighted MRI (DWI) has potential as a “rapid supplemental screening tool,” according to a study published in the American Journal of Roentgenology. Their findings show that DWI can help radiologists see mammographically occult cancers in at-risk women with dense breasts.

Lantheus Holdings, the parent company of global imaging manufacturer Lantheus Medical Imaging, has announced the first commercial shipment of Xenon Xe 133 Gas (Xenon 133), an imaging agent used when imaging the lungs, using unprocessed radiochemical Xenon 133 from Belgium’s Institute for Radioelements (IRE).